Korro Bio, Inc.
KRRO· Nasdaq
KRROKorro Bio, Inc.
Filed May 14, 2020 · 10-Q · 44 days after period end · 0001564590-20-025273
| Metric | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|
| Revenue | $7.26M | — | — |
| Net Income | -$4.91M | -$5.83M | -$4.15M |
| EPS Diluted | -$0.16 | -$3.24 | -$3.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Korro Bio, Inc. · CIK 1703647 · Engraved from SEC EDGAR
ended Mar 31, 2020 · filed May 14, 2020 · 44 d after period end
